Beyond Splicing: How TDP-43 Loss Rewrites RNA’s Final Chapter in Neurodegeneration
The Central Role of TDP-43 in Neuronal Health In the intricate landscape of neurodegenerative diseases, TAR DNA/RNA-binding protein 43 (TDP-43)…
The Central Role of TDP-43 in Neuronal Health In the intricate landscape of neurodegenerative diseases, TAR DNA/RNA-binding protein 43 (TDP-43)…
Revolutionizing Liquid Biopsy Through Advanced Single-Cell Phenotyping In a significant advancement for cancer diagnostics, researchers have developed a sophisticated deep…
Scientists have identified specific gut bacteria capable of producing serotonin independently, potentially revolutionizing IBS treatment. These microbes restored normal bowel function in animal studies and were found at lower levels in IBS patients.
Researchers from the University of Gothenburg have made a significant discovery that could transform treatment approaches for irritable bowel syndrome (IBS), according to their newly published findings. The study reveals that two specific gut bacteria—Limosilactobacillus mucosae and Ligilactobacillus ruminis—can independently produce biologically active serotonin, a neurotransmitter crucial for digestive health.
Next-Generation HAR Technologies Transforming Disability Assistance The landscape of human activity recognition is undergoing a remarkable transformation, particularly in the…
Novel Multi-Target Approach to Alzheimer’s Treatment Researchers have developed a groundbreaking series of chalcone-based compounds that demonstrate significant potential as…
Unexpected Synergy: mRNA Vaccines and Cancer Immunotherapy In a remarkable twist of medical fate, the same mRNA technology that helped…
Breakthrough in Intensive Care Diagnostics In a significant advancement for critical care medicine, researchers have demonstrated how nanopore long-read genome…
The New Era of Personalized Preventive Care In today’s digitally-driven world, personalized experiences have become the expectation rather than the…
OpenEvidence’s Meteoric Valuation Jump In a stunning demonstration of investor confidence in healthcare artificial intelligence, OpenEvidence has secured $200 million…
The Elusive Nature of HIV For decades, HIV has remained one of medicine’s most formidable adversaries, not because we lack…